IRIS Accounts Production v24.2.0.383 09953365 director 1.7.23 30.6.24 30.6.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh099533652023-06-30099533652024-06-30099533652023-07-012024-06-30099533652022-06-30099533652022-07-012023-06-30099533652023-06-3009953365ns15:EnglandWales2023-07-012024-06-3009953365ns14:PoundSterling2023-07-012024-06-3009953365ns10:Director12023-07-012024-06-3009953365ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3009953365ns10:SmallEntities2023-07-012024-06-3009953365ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3009953365ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3009953365ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3009953365ns10:FullAccounts2023-07-012024-06-3009953365ns10:RegisteredOffice2023-07-012024-06-3009953365ns5:CurrentFinancialInstruments2024-06-3009953365ns5:CurrentFinancialInstruments2023-06-3009953365ns5:Non-currentFinancialInstruments2024-06-3009953365ns5:Non-currentFinancialInstruments2023-06-3009953365ns5:ShareCapital2024-06-3009953365ns5:ShareCapital2023-06-3009953365ns5:RetainedEarningsAccumulatedLosses2024-06-3009953365ns5:RetainedEarningsAccumulatedLosses2023-06-3009953365ns5:PlantMachinery2023-07-012024-06-3009953365ns5:PlantMachinery2023-06-3009953365ns5:PlantMachinery2024-06-3009953365ns5:PlantMachinery2023-06-3009953365ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-07-012024-06-3009953365ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-06-3009953365ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-06-3009953365ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-06-30099533651ns10:Director12023-06-30099533651ns10:Director12022-06-30099533651ns10:Director12023-07-012024-06-30099533651ns10:Director12022-07-012023-06-30099533651ns10:Director12024-06-30099533651ns10:Director12023-06-30
REGISTERED NUMBER: 09953365 (England and Wales)















STEM CELL VET LTD

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2024






STEM CELL VET LTD (REGISTERED NUMBER: 09953365)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 June 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


STEM CELL VET LTD

COMPANY INFORMATION
for the Year Ended 30 June 2024







DIRECTOR: S Halperin





REGISTERED OFFICE: 1 Abacus House
Newlands Road
Corsham
Wiltshire
SN13 0BH





REGISTERED NUMBER: 09953365 (England and Wales)





ACCOUNTANT: Clear Vision Accountancy Limited
1 Abacus House
Newlands Road
Corsham
Wiltshire
SN13 0BH

STEM CELL VET LTD (REGISTERED NUMBER: 09953365)

BALANCE SHEET
30 June 2024

30/6/24 30/6/23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 25,422 5,047

CURRENT ASSETS
Stocks 6,635 21,653
Debtors 5 372,396 374,435
Cash at bank and in hand 104 29,799
379,135 425,887
CREDITORS
Amounts falling due within one year 6 748,869 561,444
NET CURRENT LIABILITIES (369,734 ) (135,557 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(344,312

)

(130,510

)

CREDITORS
Amounts falling due after more than one
year

7

13,400

47,713
NET LIABILITIES (357,712 ) (178,223 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (357,713 ) (178,224 )
(357,712 ) (178,223 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 28 November 2024 and were signed by:





S Halperin - Director


STEM CELL VET LTD (REGISTERED NUMBER: 09953365)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 June 2024

1. STATUTORY INFORMATION

Stem Cell Vet Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 33% on cost, 25% on cost and 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2023 - 2 ) .

STEM CELL VET LTD (REGISTERED NUMBER: 09953365)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 June 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 July 2023 17,059
Additions 29,988
At 30 June 2024 47,047
DEPRECIATION
At 1 July 2023 12,012
Charge for year 9,613
At 30 June 2024 21,625
NET BOOK VALUE
At 30 June 2024 25,422
At 30 June 2023 5,047

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
Additions 22,729
At 30 June 2024 22,729
DEPRECIATION
Charge for year 5,209
At 30 June 2024 5,209
NET BOOK VALUE
At 30 June 2024 17,520

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/6/24 30/6/23
£    £   
Trade debtors 104,173 150,385
Amounts owed by group undertakings 184,504 93,219
Other debtors 83,719 130,831
372,396 374,435

STEM CELL VET LTD (REGISTERED NUMBER: 09953365)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 June 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30/6/24 30/6/23
£    £   
Bank loans and overdrafts 78,765 45,763
Hire purchase contracts 7,198 -
Trade creditors 149,876 86,341
Amounts owed to group undertakings 214,942 185,706
Taxation and social security (1,413 ) 89,657
Other creditors 299,501 153,977
748,869 561,444

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
30/6/24 30/6/23
£    £   
Bank loans 5,283 47,713
Hire purchase contracts 8,117 -
13,400 47,713

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 June 2024 and 30 June 2023:

30/6/24 30/6/23
£    £   
S Halperin
Balance outstanding at start of year (87,845 ) (37,792 )
Amounts advanced 220,736 (106,071 )
Amounts repaid (376,471 ) 56,018
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (243,580 ) (87,845 )

There are no fixed repayment terms and no interest is currently being paid.

9. RELATED PARTY DISCLOSURES

During the year loans were made from the following companies, of which Stewart Halperin is the sole director and shareholder:

2024 2023
H is for Honey Limited £73,574 (£12,278 )
C is for Cat Limited £135,782 £185,705
G is for Giraffe Limited (£172,691 ) (£80,941 )
Polden Hills Veterinary Centre Ltd £5,587 -
BBounce Limited (£11,814 ) -

There are no fixed repayment terms and no interest is currently being paid.